Segars Simon 4

What Happened Simon Segars, a director of Dolby Laboratories (DLB), was granted 3,908 restricted stock units (RSUs) on February 3, 2026. The grant was recorded at $0.00 per unit (an award rather than a purchase or sale); each RSU represents a contingent right to one share of Class A common stock upon vesting.

Key Details

• Transaction date: 2026-02-03 (Form 4 filed 2026-02-05).
• Transaction type/code: Award/Grant (A); grant price reported as $0.00.
• Shares/units granted: 3,908 RSUs.
• Shares held after transaction: Includes 3,908 shares underlying RSUs, which remain subject to forfeiture until vesting.
• Vesting: RSUs vest on the earlier of (i) the first anniversary of the grant date or (ii) the day before Dolby’s 2027 annual meeting, provided Segars continues to serve on the board.
• Filing timeliness: Filed within the standard reporting window (not marked late).

Context

• This was a compensation award to a board member, not an open-market purchase or sale; such grants are routine for directors and reflect compensation, not a direct cash investment by the insider.
• Because these are restricted units, they do not convey ownership or saleable shares until they vest and any forfeiture constraints lapse.